Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 April 2025 | Story Onthatile Tikoe | Photo Supplied
Louzanne Coetzee
Louzanne Coetzee, a visually impaired Paralympic champion, has been elected to SASCOC’s Athletes Commission.

Louzanne Coetzee, a Paralympian and trailblazer in South African sport, has always embodied resilience, determination, and a passion for pushing boundaries. Recently, Coetzee achieved another milestone in her career – being selected to serve on the Athletes Commission of the South African Sports Confederation and Olympic Committee (SASCOC) for the next Olympic and Paralympic cycle. For Coetzee, this recognition is not just a personal achievement but an opportunity to drive meaningful change for athletes, particularly those with disabilities.

“Being selected as part of the SASCOC Athletes Commission is a great privilege,” she says. “It gives me the opportunity to represent athletes at the SASCOC level and take their issues forward. I was part of the previous commission, and I look forward to building on the work we have already started.”

As a visually impaired (classification T11) athlete with a distinguished career, Coetzee’s experiences inform her approach to this new role. Although she is not directly part of the SASCOC board, her seat on the Athletes Commission allows her to act as a crucial advocate for athletes, contributing to decisions that impact South African sport. “The commission will have its training soon, and we will learn more about our new responsibilities there,” she explains. “But my focus is clear: I want to improve classification opportunities for para-athletes and contribute towards enhancing high-performance athlete support in South Africa.”

Her vision extends beyond just the athletes she represents – she recognises the unique challenges that athletes with disabilities face. “The drive to succeed needs to come from within. You, as an athlete, are responsible for your performance, and that mindset is essential,” Coetzee says. She adds that the commission hosts athlete indabas, where athletes can voice their concerns and share the challenges they face. “We will continue to address these issues and work towards solutions that make a real difference.”

Coetzee has a clear message for young athletes with disabilities: “Your drive for success needs to be part of who you are. You alone control whether you succeed. And when challenges arise, don’t be afraid to voice them and seek assistance. Be creative in finding solutions to your unique challenges.”

Her advice extends beyond the competitive arena. After balancing a successful athletic and academic career with leadership aspirations, she emphasises the importance of time management for those seeking to excel both in sport and leadership. “It might be hard to do both, but it’s achievable if you plan properly,” she says, offering valuable guidance for aspiring athletes who wish to follow in her footsteps.

Her passion for improving inclusivity and accessibility in South African sport drives her to advocate for greater awareness of para-sports. “I want more people to know these athletes and support them on their journey,” she says. “There needs to be more awareness regarding para-sport, and as athletes we need to speak up. If we don’t, things won’t change for the betterment of us as athletes.”

Despite her incredible achievements, Coetzee remains motivated by a simple love for her sport. “I really enjoy what I do. It’s not just a job; it’s a passion,” she says. She also emphasises the importance of diverse representation on boards like SASCOC. “It’s vital that athletes have a say in the decision-making processes that impact their careers,” she says. “If we don’t speak up, things won’t change.”

Her success is also a testament to the support and opportunities she has received throughout her journey. “Everyone at the University of the Free State (UFS), especially KovsieSport and the Centre for Universal Access and Disability Support (CUADS), has played a major role in my success,” she says. “The support has helped me compete at the highest level while remaining academically strong. I am truly honoured to be backed by such a great institution.”

Finally, Coetzee calls on the public to help raise awareness and support for athletes with disabilities. “Show support for these athletes, be interested in the sports they play, and watch Paralympic sports when available. Be vocal about your support, as that can make a huge difference in recognition and opportunity,” she encourages.

As Louzanne Coetzee continues to break barriers and inspire others, her commitment to improving the lives of athletes, especially those with disabilities, remains unwavering. Through her leadership on the SASCOC Athletes Commission, she is not just advocating for athletes today but also paving the way for future generations to succeed in an inclusive and supportive sporting environment.

News Archive

Research contributes to improving quality of life for cancer patients
2016-11-21

Description: Inorganic Chemistry supervisors  Tags: Inorganic Chemistry supervisors

Inorganic Chemistry supervisors in the Radiopharmacy
Laboratory during the preparation of a typical complex
mixture to see how fast it reacts. Here are, from the left,
front: Dr Marietjie Schutte-Smith, Dr Alice Brink
(both scholars from the UFS Prestige
Scholar Programme), and Dr Truidie Venter (all three
are Thuthuka-funded researchers).
Back: Prof André Roodt and Dr Johan Venter.
Photo: Supplied

Imagine that you have been diagnosed with bone cancer and only have six months to live. You are in a wheelchair because the pain in your legs is so immense that you can’t walk anymore – similar to a mechanism eating your bones from the inside.

You are lucky though, since you could be injected with a drug to control the pain so effective that you will be able to get out of the wheelchair within a day-and-a-half and be able to walk again. Real-life incidents like these provide intense job satisfaction to Prof André Roodt, Head of Inorganic Chemistry at the University of the Free State (UFS). The research, which is conducted by the Inorganic Group at the UFS, contributes greatly to the availability of pain therapy that does not involve drugs, but improves the quality of life for cancer patients.

The research conducted by the Inorganic Group under the leadership of Prof Roodt, plays a major role in the clever design of model medicines to better detect and treat cancer.

The Department of Chemistry is one of approximately 10 institutions worldwide that conducts research on chemical mechanisms to identify and control cancer. “The fact that we are able to cooperate with the Departments of Nuclear Medicine and Medical Physics at the UFS, the Animal Research Centre, and other collaborators in South Africa and abroad, but especially the methodology we utilise to conduct research (studying the chemical manner in which drugs are absorbed in cancer as well as the time involved), enhances the possibility of making a contribution to cancer research,” says Prof Roodt.

Technique to detect cancer spots on bone
According to the professor, there are various ways of detecting cancer in the body. Cancer can, inter alia, be identified by analysing blood, X-rays (external) or through an internal technique where the patient is injected with a radioactive isotope.

Prof Roodt explains: “The doctor suspects that the patient has bone cancer and injects the person with a drug consisting of an isotope (only emits X-rays and does no damage to tissue) that is connected to a phosphonate (similar to those used for osteoporosis). Once the drug is injected, the isotope (Technetium-99m) moves to the spot on the bone where the cancer is located. The gamma rays in the isotope illuminate the area and the doctor can see exactly where treatment should be applied. The Technetium-99m has the same intensity gamma rays as normal X-rays and therefore operates the same as an internal X-ray supply.” With this technique, the doctor can see where the cancer spots are within a few hours.

The same technique can be used to identify inactive parts of the brain in Alzheimer patients, as well as areas of the heart where there is no blood supply or where the heart muscle is dead.

Therapeutic irradiation of cancer
For the treatment of pain connected with cancer, the isotope Rhenium-186 is injected. Similar to the manner in which the Technetium-99m phosphonate compound is ingested into the body, the Rhenium-186 phosphonate travels to the cancer spots. Patients thus receive therapeutic irradiation – a technique known as palliative therapy, which is excellent for treating pain. A dosage of this therapy usually lasts for about two months.

The therapy is, however, patient specific. The dosages should correspond with the occurrence and size of cancer spots in the patient’s body. First, the location of the cancer will be determined by means of a technetium scan. After that, the size of the area where the cancer occurs has to be determined. The dosage for addressing total pain distribution will be calculated according to these results.

Technique to detect cancer spots on soft tissue
Another technique to detect cancer as spots on bone or in soft tissue and organs throughout the body is by utilising a different type of irradiation, a so-called PET isotope. The Fluor-18 isotope is currently used widely, and in Pretoria a machine called a cyclotron was produced by Dr Gerdus Kemp, who is a former PhD graduate from the Inorganic Research Group. The F-18 is then hidden within a glucose molecule and a patient will be injected with the drug after being tranquillised and after the metabolism has been lowered considerably. The glucose, which is the ‘food' that cancer needs to grow, will then travel directly to the cancer area and the specific area where the cancer is located will thus be traced and ‘illuminated’ by the Fluor-18, which emits its own 'X-rays'.

In the late 80s, Prof Roodt did his own postdoctoral study on this research in the US. He started collaborating with the Department of Nuclear Medicine at the UFS in the early 90s, when he initiated testing for this research.

Through their research of more than 15 years, the Inorganic Group in the Department of Chemistry has made a major contribution to cancer research. Research on mechanisms for the detection of cancer, by designing new clever chemical agents, and the chemical ways in which these agents are taken up in the body, especially contributes to the development in terms of cancer therapy and imaging, and has been used by a number of hospitals in South Africa.

The future holds great promise
Prof Roodt and his team are already working on a bilateral study between the UFS and Kenya. It involves the linking of radio isotopes, as mentioned above, to known natural products (such as rooibos tea), which possess anti-cancer qualities.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept